Precise™ Oncology Solutions:

Helping you find treatment clarity in cancer complexity

Get started

Precise™ Oncology Solutions:

Helping you find treatment clarity in cancer complexity

Discover a clearer path to better outcomes with a simpler testing experience

You navigate the intricate world of cancer treatment every day to provide the best outcomes for each patient and their unique treatment journey. Yet, clinically actionable information can be difficult to obtain in a timely manner with multiple orders on different platforms, and long turnaround times.

One simple order.

Comprehensive results.

Test for germline and somatic biomarkers in one order with Precise™ Oncology Solutions

Precise Oncology Solutions provides a streamlined testing experience that gives you the ability to receive results for comprehensive germline testing, tumor profiling and companion diagnosic options, including HRD† testing with one order.

Precise Logo Black
Germline

Germline
(FDA-Approved)

BRACAnalysisCDx

Germline
(Non-FDA-Approved)

MyRisk
HRD status
Tumor profiling

HRDstatus
(FDA-Approved)

MyChoiceCDx
Tumor profiling

Tumor profilingstatus
(Non-FDA-Approved)

Precise Tumor

For patients with ovarian cancer
Precise Tumor is powered by Intermountain Precision Genomics, a service of Intermountain® Healthcare

Request Access

To get enrolled in Precise Oncology Solutions and start your new testing experience, please fill out the information request form below and you will be connected with your dedicated Myriad account manager.







Hidden Fields











Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Treating cancer is complex, but your testing experience doesn’t need to be

Testing experience
  • Save time with a streamlined ordering process for multiple tests
  • Companion diagnostic treatment eligibility enables more treatment options for appropriate patients
  • Fast delivery of results through our secure portal
  • Summary sheet to help clarify actionable results after all tests are completed

Get the genetic insights you need for treatment decisions

  • FDA-approved companion diagnostic options
  • Germline testing
  • Myriad HRD Status
  • TMB
  • MSI
  • PD-L1
  • 500+ genes including clinically actionable biomarkers for all solid tumor types

Precise Oncology Solutions

  • Tumor blocks sent to a single location
  • Identify patients who may benefit from PARP inhibitor therapy
  • Identify patients who may qualify for clinical trials
  • Optional participation in Molecular Tumor Board
  • PD-L1 available as an add-on (if Precise Tumor testing is ordered)
  • Optional enrollment in treatment registry (if Precise Tumor testing is ordered)

Precise Oncology Solutions allows you to order both germline and somatic testing in one seamless experience

Your patients are looking to you for the best possible treatment options. Set your patients up for the best outcomes with somatic and germline testing. These genetic insights will not only help you make treatment decisions but can also aid your network of colleagues as they interact with and assess your patient for additional care.

The combination of germline AND somatic testing can help determine comprehensive treatment options, earlier and faster:

Seamless testing experience
  1. Robson M, et al. N Engl J Med. 2018; 377;523-533
  2. Golan T, et al. N Engl J Med. 2019; 381(4);317-327.
  3. Moore KN, et al. N Engl J Med. 2019; 379(26):2495-2505
  4. Bono et al. Olaparib for Metastatic Castration-Resistant Prostate Cancer N Engl J Med. ePub April 28, 2020

How to order

We’ve made it quick and simple to order all the necessary germline, somatic and HRD tests for each patient in one easy-to-use online portal experience.

  1. Fill out a test request form in the Myriad Genetics provider portal
  2. Submit a blood or saliva sample for your patient’s germline test
  3. Our laboratory processing staff will contact your pathology partner directly to obtain the tumor sample for any somatic or HRD testing that is ordered

Clarity starts here

Each test result is reported out as it becomes available in the portal, and you will be provided with an easy-to-interpret summary sheet for all tests ordered for each patient. Upon receipt of all reports, you will receive a high-level summary sheet*, signaling all results are in, and allowing you to minimize your time in report review.

Selecting optimal tissue specimen for a successful Precise Tumor or MyChoice® CDx test

*Summary sheet includes information from both FDA-approved and non-FDA-approved tests and will be reflective of the specific tests ordered for each patient

Myriad Genetics Monthly Molecular Tumor Board

Join us each month to convene with clinical experts to provide state-of-the-art and evidence-based assessment of cases.

Topics can include:

  • Targeted therapy options based on genomic data
  • Prior lines of treatment and their impact on additional lines of therapy
  • Potential hereditary implications of genomic findings

This is not a CME event